- Home
- PRG vs RCKT Comparison
PRG vs RCKT Comparison
Compare PRG & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRG
- RCKT
- Stock Information
- Founded
- PRG 2020
- RCKT 1999
- Country
- PRG United States
- RCKT United States
- Employees
- PRG N/A
- RCKT N/A
- Industry
- PRG Diversified Commercial Services
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- PRG Consumer Discretionary
- RCKT Health Care
- Exchange
- PRG Nasdaq
- RCKT Nasdaq
- Market Cap
- PRG 1.8B
- RCKT 1.3B
- IPO Year
- PRG N/A
- RCKT N/A
- Fundamental
- Price
- PRG $42.29
- RCKT $12.72
- Analyst Decision
- PRG Buy
- RCKT Strong Buy
- Analyst Count
- PRG 6
- RCKT 11
- Target Price
- PRG $53.00
- RCKT $50.27
- AVG Volume (30 Days)
- PRG 366.4K
- RCKT 1.6M
- Earning Date
- PRG 02-19-2025
- RCKT 02-24-2025
- Dividend Yield
- PRG 1.14%
- RCKT N/A
- EPS Growth
- PRG 8.67
- RCKT N/A
- EPS
- PRG 3.58
- RCKT N/A
- Revenue
- PRG $2,417,577,000.00
- RCKT N/A
- Revenue This Year
- PRG $2.85
- RCKT N/A
- Revenue Next Year
- PRG $6.70
- RCKT $233,736.97
- P/E Ratio
- PRG $11.80
- RCKT N/A
- Revenue Growth
- PRG N/A
- RCKT N/A
- 52 Week Low
- PRG $27.84
- RCKT $11.15
- 52 Week High
- PRG $50.28
- RCKT $31.47
- Technical
- Relative Strength Index (RSI)
- PRG 36.80
- RCKT 47.75
- Support Level
- PRG $41.00
- RCKT $11.56
- Resistance Level
- PRG $43.22
- RCKT $12.32
- Average True Range (ATR)
- PRG 1.48
- RCKT 0.71
- MACD
- PRG -0.14
- RCKT 0.20
- Stochastic Oscillator
- PRG 16.60
- RCKT 66.81
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The Company has two reportable segments: (i) Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and (ii) Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the progressive leasing segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.